Followers | 74 |
Posts | 4488 |
Boards Moderated | 2 |
Alias Born | 08/21/2015 |
Friday, February 09, 2024 2:47:18 PM
Recent ATAI News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 01:19:56 PM
- atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 11/13/2024 01:00:00 PM
- Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer • GlobeNewswire Inc. • 11/11/2024 12:30:00 PM
- atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit • GlobeNewswire Inc. • 10/15/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:32:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:30:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:30:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:02:03 PM
- atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 11:00:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:23:44 AM
- atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 08/13/2024 11:10:00 AM
- atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT) • GlobeNewswire Inc. • 08/13/2024 11:00:00 AM
- atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference • GlobeNewswire Inc. • 06/26/2024 11:00:17 AM
- atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a • GlobeNewswire Inc. • 06/20/2024 11:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:00:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 12:00:49 PM
- atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference • GlobeNewswire Inc. • 05/31/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 11:10:17 AM
- atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors • GlobeNewswire Inc. • 05/23/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 09:30:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 11:53:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 11:15:45 AM
ILUS Agrees to Swap Majority Stake in Quality Industrial Corp. for Future Majority Stake in Fusion Fuel Green (NASDAQ: HTOO) • ILUS • Nov 20, 2024 9:07 AM
Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market with Vision AI Software • AVAI • Nov 20, 2024 8:00 AM
Geo-Political Tensions and Trump's Increasing Military Budgets Could Boost Demand for Actelis' Cyber Hardened Networking Tech ($ASNS) • ASNS • Nov 19, 2024 10:24 AM
Key Metals Surge, Unlocking New Opportunities for Savvy Mining Investors • GDXJ • Nov 19, 2024 8:45 AM
Greenlane Signs New U.S. Distribution Agreement with Veriteque USA, Manufacturer of the SwabTek™ and Verifique™ Brand of Field Test Kits • GNLN • Nov 19, 2024 8:34 AM
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary • CBDL • Nov 19, 2024 8:00 AM